STOCK TITAN

Nyxoah SA - NYXH STOCK NEWS

Welcome to our dedicated news page for Nyxoah SA (Ticker: NYXH), a resource for investors and traders seeking the latest updates and insights on Nyxoah SA.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nyxoah SA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nyxoah SA's position in the market.

Rhea-AI Summary
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) received a transparency notification from Deerfield Partners, L.P. indicating that they crossed the 3% threshold on November 30, 2023, holding 856,085 shares, representing 2.99% of the total number of voting rights on November 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announced the appointment of Francis Kim as Chief Regulatory and Quality Officer. With over 25 years of experience in the healthcare industry, Francis will lead Nyxoah’s Global Regulatory and Quality departments. His previous roles at Medtronic, Philips, and other companies make him a valuable addition to Nyxoah during a crucial period, with the DREAM U.S. pivotal study data expected in early 2024 and FDA approval anticipated by the end of the year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
management
-
Rhea-AI Summary
Nyxoah SA (NYXH) to Participate in Piper Sandler 35th Annual Healthcare Conference. Olivier Taelman, CEO, to Speak at Fireside Chat on November 29, 2023, at 2:30pm ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
conferences
Rhea-AI Summary
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) reported financial and operating results for Q3 2023, including a commercial partnership with ResMed Germany to increase OSA awareness and therapy penetration. The company ended the quarter with €1.0 million in sales, €72.5 million in cash, and accelerated U.S. pre-commercialization efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.1%
Tags
-
Rhea-AI Summary
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) to Participate in Jefferies London Healthcare Conference, CEO to Deliver Corporate Update on November 15, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.16%
Tags
conferences
-
Rhea-AI Summary
Nyxoah SA will release its third quarter 2023 financial results on November 8, 2023, after market close. A conference call will be held to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.92%
Tags
Rhea-AI Summary
Nyxoah partners with ResMed Germany to increase OSA awareness and therapy penetration in the German market, aiming to guide patients from diagnosis to the right treatment. The partnership aims to educate patients and clinicians through helplines, marketing initiatives, and educational programs. The goal is to enable more patients to receive effective, personalized therapy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
partnership
-
Rhea-AI Summary
Nyxoah to Participate in Cantor Fitzgerald Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.6%
Tags
conferences
-
Rhea-AI Summary
Nyxoah to participate in upcoming investor conferences in New York City.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.8%
Tags
conferences
Rhea-AI Summary
Nyxoah SA publishes information on the total number of voting rights and shares.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.16%
Tags
none
Nyxoah SA

Nasdaq:NYXH

NYXH Rankings

NYXH Stock Data

276.66M
10.98M
45.19%
23.81%
0.9%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Belgium
Mont Saint Guibert

About NYXH

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).